Apic Bio

graphic image of neurons and synapses

Biotech

UniQure snags rare ALS therapy from Apic Bio for $10M upfront

UniQure is paying $10 million in upfront cash to Apic Bio to scoop up a preclinical gene therapy aimed at a rare form of ALS.

Max Bayer Jan 31, 2023 10:45am

parachute jump

Apic brings on Solid Bio vet Quiroz to CMO role—Chutes & Ladders

Aug 28, 2020 9:30am